| 1 |
32782434 |
10.1186/s12935-020-01457-8 |
2022 |
Evaluation of the upregulation and surface expression of hypoxanthine guanine phosphoribosyltransferase in acute lymphoblastic leukemia and Burkitt's B cell lymphoma. |
MSH2 |
| 2 |
33928678 |
10.1111/den.14004 |
2022 |
Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin's lymphoma survivors. |
MSH2 |
| 3 |
34538134 |
10.1177/03009858211022704 |
2022 |
Mismatch repair deficiency in canine neoplasms. |
MSH2 |
| 4 |
34761252 |
10.1093/jjco/hyab173 |
2022 |
A novel Lynch syndrome pedigree bearing germ-line MSH2 missense mutation c.1808A>T (Asp603Val). |
MSH2 |
| 5 |
34787334 |
10.1111/pde.14861 |
2022 |
Eruptive nevi in a patient with constitutional mismatch repair deficiency (CMMRD). |
MSH2 |
| 6 |
34973016 |
10.1007/978-3-030-78775-2_14 |
2022 |
Adiponectin and Its Effects on Acute Leukemia Cells: An Experimental and Bioinformatics Approach. |
MSH2 |
| 7 |
35812033 |
10.1136/flgastro-2022-102123 |
2022 |
Diagnosis and management of Lynch syndrome. |
MSH2 |
| 8 |
36097110 |
10.1007/s11033-022-07761-y |
2022 |
Looking beyond the cytogenetics in haematological malignancies: decoding the role of tandem repeats in DNA repair genes. |
MSH2 |
| 9 |
32022486 |
10.1002/cam4.2870 |
2021 |
Microsatellite instability and its associations with the clinicopathologic characteristics of diffuse large B-cell lymphoma. |
MSH2 |
| 10 |
33191405 |
10.1038/s41388-020-01542-2 |
2021 |
Germline variants of DNA repair genes in early onset mantle cell lymphoma. |
MSH2 |
| 11 |
34086170 |
10.1007/s10549-021-06258-9 |
2021 |
Double heterozygotes of BRCA1/BRCA2 and mismatch repair gene pathogenic variants: case series and clinical implications. |
MSH2 |
| 12 |
28761921 |
10.1016/j.jdcr.2017.04.007 |
2020 |
A possible association between mycosis fungoides and Muir-Torre syndrome: Two disorders with microsatellite instability. |
MSH2 |
| 13 |
28943948 |
10.3892/ol.2017.6721 |
2020 |
Analysis of the expression level and methylation of tumor protein p53, phosphatase and tensin homolog and mutS homolog 2 in N-methyl-N-nitrosourea-induced thymic lymphoma in C57BL/6 mice. |
MSH2 |
| 14 |
29510549 |
10.3390/cancers10030064 |
2020 |
The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability. |
MSH2 |
| 15 |
31697823 |
10.1182/blood.2019002220 |
2020 |
Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia. |
MSH2 |
| 16 |
33143351 |
10.3390/pathogens9110909 |
2020 |
Bovine Leukemia Virus Infection Affects Host Gene Expression Associated with DNA Mismatch Repair. |
MSH2 |
| 17 |
29892060 |
10.1038/s41591-018-0043-5 |
2019 |
DNA repair processes are critical mediators of p53-dependent tumor suppression. |
MSH2 |
| 18 |
29904176 |
10.1038/s41431-018-0197-0 |
2019 |
Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD). |
MSH2 |
| 19 |
30551794 |
10.1016/j.bulcan.2018.10.008 |
2019 |
[Constitutional MMR deficiency: Genetic bases and clinical implications]. |
MSH2 |
| 20 |
30734108 |
10.1007/s00428-019-02528-6 |
2019 |
Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma. |
MSH2 |
| 21 |
28142295 |
10.1080/10428194.2017.1283029 |
2018 |
Identification of a tumor suppressor network in T-cell leukemia. |
MSH2 |
| 22 |
28728506 |
10.1080/10245332.2017.1354428 |
2018 |
Microsatellite Instability and Promoter Hypermethylation of DNA repair genes in Hematologic Malignancies: a forthcoming direction toward diagnostics. |
MSH2 |
| 23 |
28856790 |
10.1111/ped.13365 |
2018 |
MSH2 deletion with CREBBP and KRAS mutations in pediatric high-hyperdiploid acute lymphoblastic leukemia. |
MSH2 |
| 24 |
28923119 |
10.1186/s13000-017-0645-0 |
2018 |
ALK-positive gastric inflammatory myofibroblastic tumor in an adult with familial adenomatous polyposis and diffuse fundic polyposis. |
MSH2 |
| 25 |
29439113 |
10.1136/gutjnl-2016-312608 |
2018 |
Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment. |
MSH2 |
| 26 |
29496532 |
10.1016/j.exphem.2018.02.006 |
2018 |
Deficiency in the DNA glycosylases UNG1 and OGG1 does not potentiate c-Myc-induced B-cell lymphomagenesis. |
MSH2 |
| 27 |
30043858 |
10.1590/1414-431X20187588 |
2018 |
Decreased expression of chromodomain helicase DNA-binding protein 9 is a novel independent prognostic biomarker for colorectal cancer. |
MSH2 |
| 28 |
27017609 |
10.1007/s10689-016-9894-4 |
2017 |
MSI detection and its pitfalls in CMMRD syndrome in a family with a bi-allelic MLH1 mutation. |
MSH2 |
| 29 |
27783137 |
10.1007/s00432-016-2294-1 |
2017 |
A specific mode of microsatellite instability is a crucial biomarker in adult T-cell leukaemia/lymphoma patients. |
MSH2 |
| 30 |
28562508 |
10.1097/MPH.0000000000000863 |
2017 |
Biallelic PMS2 Mutation and Heterozygous DICER1 Mutation Presenting as Constitutional Mismatch Repair Deficiency With Corpus Callosum Agenesis: Case Report and Review of Literature. |
MSH2 |
| 31 |
28767666 |
10.1371/journal.pone.0182175 |
2017 |
Mismatch repair deficient hematopoietic stem cells are preleukemic stem cells. |
MSH2 |
| 32 |
28981733 |
10.1093/jjco/hyx098 |
2017 |
Prognostic factors for primary central nervous system lymphomas treated with high-dose methotrexate-based chemo-radiotherapy. |
MSH2 |
| 33 |
25978431 |
10.1038/bcj.2015.35 |
2016 |
NPM-ALK mediates phosphorylation of MSH2 at tyrosine 238, creating a functional deficiency in MSH2 and the loss of mismatch repair. |
MSH2 |
| 34 |
26022687 |
10.1159/000381675 |
2016 |
Role of Red Meat and Resistant Starch in Promutagenic Adduct Formation, MGMT Repair, Thymic Lymphoma and Intestinal Tumourigenesis in Msh2 -Deficient Mice. |
MSH2 |
| 35 |
26318770 |
10.1136/jmedgenet-2015-103299 |
2016 |
Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort. |
MSH2 |
| 36 |
26327213 |
10.18632/oncotarget.4638 |
2016 |
Azathioprine induction of tumors with microsatellite instability: risk evaluation using a mouse model. |
MSH2 |
| 37 |
26385350 |
10.1182/blood-2015-02-628164 |
2016 |
AID-associated DNA repair pathways regulate malignant transformation in a murine model of BCL6-driven diffuse large B-cell lymphoma. |
MSH2 |
| 38 |
26544533 |
10.1002/pbc.25818 |
2016 |
Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity. |
MSH2 |
| 39 |
26558945 |
10.1615/critreveukaryotgeneexpr.2015013893 |
2016 |
Genes Associated with Human Cancers: Their Expressions, Features, Functions, and Significance. |
MSH2 |
| 40 |
26743104 |
10.1016/j.ejmg.2015.12.014 |
2016 |
Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome. |
MSH2 |
| 41 |
26743341 |
10.1016/j.bbmt.2015.12.022 |
2016 |
Impact of Polymorphic Variations of Gemcitabine Metabolism, DNA Damage Repair, and Drug-Resistance Genes on the Effect of High-Dose Chemotherapy for Relapsed or Refractory Lymphoid Malignancies. |
MSH2 |
| 42 |
24990612 |
10.1038/leu.2014.210 |
2015 |
PKCζ and PKMζ are overexpressed in TCF3-rearranged paediatric acute lymphoblastic leukaemia and are associated with increased thiopurine sensitivity. |
MSH2 |
| 43 |
24013230 |
10.1038/onc.2013.365 |
2014 |
The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break repair and mismatch repair. |
MSH2 |
| 44 |
24528056 |
10.7314/apjcp.2014.15.1.355 |
2014 |
Aberrant DNA methylation and epigenetic inactivation of hMSH2 decrease overall survival of acute lymphoblastic leukemia patients via modulating cell cycle and apoptosis. |
MSH2 |
| 45 |
22848414 |
10.1371/journal.pone.0040934 |
2013 |
IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia. |
MSH2 |
| 46 |
22916837 |
10.3109/10428194.2012.723211 |
2013 |
Analysis of microsatellite instability in gastric mucosa-associated lymphoid tissue lymphoma. |
MSH2 |
| 47 |
23066952 |
10.3109/10428194.2012.739687 |
2013 |
Mutation mismatch repair gene deletions in diffuse large B-cell lymphoma. |
MSH2 |
| 48 |
23610619 |
10.1177/2040620712471553 |
2013 |
The pathobiology of the oncogenic tyrosine kinase NPM-ALK: a brief update. |
MSH2 |
| 49 |
23960188 |
10.1084/jem.20122842 |
2013 |
DNA repair genes are selectively mutated in diffuse large B cell lymphomas. |
MSH2 |
| 50 |
21674763 |
10.1002/pbc.23217 |
2012 |
High-grade brain tumors in siblings with biallelic MSH6 mutations. |
MSH2 |
| 51 |
21747120 |
10.1158/1078-0432.CCR-11-0556 |
2012 |
Multicenter phase II trial of temozolomide in mycosis fungoides/sezary syndrome: correlation with O⁶-methylguanine-DNA methyltransferase and mismatch repair proteins. |
MSH2 |
| 52 |
22000951 |
10.1016/j.jcpa.2011.08.009 |
2012 |
Widespread mismatch repair expression in feline small intestinal lymphomas. |
MSH2 |
| 53 |
22083360 |
10.3791/3573 |
2012 |
Assessing somatic hypermutation in Ramos B cells after overexpression or knockdown of specific genes. |
MSH2 |
| 54 |
22433851 |
10.1074/jbc.M111.327650 |
2012 |
Ectopically expressed human tumor biomarker MutS homologue 2 is a novel endogenous ligand that is recognized by human γδ T cells to induce innate anti-tumor/virus immunity. |
MSH2 |
| 55 |
22920205 |
|
2012 |
[Constitutional mismatch repair-deficiency syndrome (CMMR-D) - a case report of a family with biallelic MSH6 mutation]. |
MSH2 |
| 56 |
21078976 |
10.1073/pnas.1015541107 |
2011 |
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). |
MSH2 |
| 57 |
21703420 |
10.1016/j.ajpath.2011.03.045 |
2011 |
Fusion tyrosine kinase NPM-ALK Deregulates MSH2 and suppresses DNA mismatch repair function novel insights into a potent oncoprotein. |
MSH2 |
| 58 |
21946537 |
10.1038/nm.2430 |
2011 |
Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells. |
MSH2 |
| 59 |
22164924 |
|
2011 |
[Management of hereditary non-polyposis syndrome (Lynch syndrome)]. |
MSH2 |
| 60 |
19874835 |
10.1016/j.taap.2009.10.015 |
2010 |
Proteomics-based safety evaluation of multi-walled carbon nanotubes. |
MSH2 |
| 61 |
19931261 |
10.1053/j.gastro.2009.11.009 |
2010 |
An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents. |
MSH2 |
| 62 |
20181625 |
|
2010 |
Molecular profiling using tissue microarrays as a tool to identify predictive biomarkers in laryngeal cancer treated with radiotherapy. |
MSH2 |
| 63 |
20233627 |
10.1016/j.leukres.2010.02.017 |
2010 |
Mismatch repair and the downstream target genes, PAX5 and Ikaros, in childhood acute lymphoblastic leukemia. |
MSH2 |
| 64 |
20567595 |
10.1371/journal.pone.0011182 |
2010 |
MSH2/MSH6 complex promotes error-free repair of AID-induced dU:G mispairs as well as error-prone hypermutation of A:T sites. |
MSH2 |
| 65 |
20923998 |
10.1093/jnci/djq389 |
2010 |
Azathioprine-induced carcinogenesis in mice according to Msh2 genotype. |
MSH2 |
| 66 |
18830263 |
10.1038/leu.2008.240 |
2009 |
Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma. |
MSH2 |
| 67 |
18955159 |
10.1016/j.mrgentox.2008.09.014 |
2009 |
Compromised repair of clustered DNA damage in the human acute lymphoblastic leukemia MSH2-deficient NALM-6 cells. |
MSH2 |
| 68 |
19131589 |
10.2353/ajpath.2009.080521 |
2009 |
Proteome-wide identification of novel binding partners to the oncogenic fusion gene protein, NPM-ALK, using tandem affinity purification and mass spectrometry. |
MSH2 |
| 69 |
19435918 |
10.1158/0008-5472.CAN-08-3292 |
2009 |
Role of MUTYH and MSH2 in the control of oxidative DNA damage, genetic instability, and tumorigenesis. |
MSH2 |
| 70 |
19551857 |
10.1002/ijc.24681 |
2009 |
The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms. |
MSH2 |
| 71 |
19837692 |
10.1073/pnas.0905965106 |
2009 |
Msh2-dependent DNA repair mitigates a unique susceptibility of B cell progenitors to c-Myc-induced lymphomas. |
MSH2 |
| 72 |
16403256 |
|
2008 |
[Abnormal expression of hMSH2 mRNA and mutation P53 protein in acute lymphoblastic leukemia]. |
MSH2 |
| 73 |
17601929 |
10.1136/jmg.2007.048942 |
2008 |
Familial T-cell non-Hodgkin lymphoma caused by biallelic MSH2 mutations. |
MSH2 |
| 74 |
17849149 |
10.1007/s00428-007-0500-x |
2008 |
Absence of mismatch repair deficiency in gastric lymphoma: an immunohistochemical study of mlh1 and msh2 protein expression. |
MSH2 |
| 75 |
17851451 |
10.1038/sj.ejhg.5201923 |
2008 |
Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1. |
MSH2 |
| 76 |
18177936 |
10.1016/j.leukres.2007.11.024 |
2008 |
Frequent microsatellite instability in non-Hodgkin lymphomas irresponsive to chemotherapy. |
MSH2 |
| 77 |
18181177 |
10.1002/gcc.20536 |
2008 |
Non-Hodgkin lymphoma related to hereditary nonpolyposis colorectal cancer in a patient with a novel heterozygous complex deletion in the MSH2 gene. |
MSH2 |
| 78 |
18593904 |
10.1158/0008-5472.CAN-08-0019 |
2008 |
Zebrafish with mutations in mismatch repair genes develop neurofibromas and other tumors. |
MSH2 |
| 79 |
17216011 |
HUON.2006.50.4.0349 |
2007 |
[Developments in cancer management by innovative genomics. 2006 report of the National Cancer Consortium]. |
MSH2 |
| 80 |
17240451 |
10.1016/j.molimm.2006.12.006 |
2007 |
Known components of the immunoglobulin A:T mutational machinery are intact in Burkitt lymphoma cell lines with G:C bias. |
MSH2 |
| 81 |
17483304 |
10.1136/jmg.2006.048660 |
2007 |
Biallelic mutation of MSH2 in primary human cells is associated with sensitivity to irradiation and altered RAD51 foci kinetics. |
MSH2 |
| 82 |
16283678 |
10.1002/ajmg.a.30998 |
2006 |
Neurofibromatosis von Recklinghausen type I phenotype and early onset of cancers in siblings compound heterozygous for mutations in MSH6. |
MSH2 |
| 83 |
16381012 |
10.1002/ijc.21686 |
2006 |
Msh2 deficiency increases susceptibility to benzo[a]pyrene-induced lymphomagenesis. |
MSH2 |
| 84 |
16507833 |
10.1093/jnci/djj073 |
2006 |
PMS2 mutations in childhood cancer. |
MSH2 |
| 85 |
17064978 |
10.1080/10428190600758587 |
2006 |
DNA repair gene inactivation in non-Hodgkin's lymphoma. |
MSH2 |
| 86 |
17064992 |
10.1080/10428190600652137 |
2006 |
Expression of DNA mismatch repair proteins in transformed non-Hodgkin's lymphoma: relationship to smoking. |
MSH2 |
| 87 |
15682421 |
10.1002/ajh.20259 |
2005 |
Reduced expression of human mismatch repair genes in adult T-cell leukemia. |
MSH2 |
| 88 |
15700306 |
10.1002/ijc.20918 |
2005 |
Diethylstilbestrol effects and lymphomagenesis in Mlh1-deficient mice. |
MSH2 |
| 89 |
15805259 |
10.1158/0008-5472.CAN-04-3158 |
2005 |
A lack of DNA mismatch repair on an athymic murine background predisposes to hematologic malignancy. |
MSH2 |
| 90 |
15944788 |
|
2005 |
Methylation of the MLH1 gene in hematological malignancies. |
MSH2 |
| 91 |
16000562 |
10.1158/1078-0432.CCR-04-2025 |
2005 |
A homozygous mutation in MSH6 causes Turcot syndrome. |
MSH2 |
| 92 |
14639654 |
10.1002/mc.10157 |
2004 |
A panel of repeat markers for detection of microsatellite instability in murine tumors. |
MSH2 |
| 93 |
14762794 |
10.1053/j.gastro.2003.11.008 |
2004 |
Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. |
MSH2 |
| 94 |
15126346 |
10.1158/0008-5472.can-03-3834 |
2004 |
Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumors. |
MSH2 |
| 95 |
11999575 |
10.1080/10428190290006215 |
2003 |
Mismatch repair gene expression in malignant lymphoproliferative disorders of B-cell origin. |
MSH2 |
| 96 |
12400605 |
10.1080/1042819021000002956 |
2003 |
Analysis of mismatch repair defects in the familial occurrence of lymphoma and colorectal cancer. |
MSH2 |
| 97 |
12471623 |
10.1002/ijc.10824 |
2003 |
Beta2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous system. |
MSH2 |
| 98 |
12479849 |
10.1016/s0145-2126(02)00078-4 |
2003 |
Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation. |
MSH2 |
| 99 |
12538346 |
10.1093/carcin/24.1.31 |
2003 |
Assessment of mismatch repair function in leukaemic cell lines and blasts from children with acute lymphoblastic leukaemia. |
MSH2 |
| 100 |
12549480 |
10.1086/345297 |
2003 |
Early onset brain tumor and lymphoma in MSH2-deficient children. |
MSH2 |
Datasets
Models
